文献速递慢阻肺呼吸道感染

支气管扩张-慢阻肺重叠中变应性支气管肺曲霉病高发

High Frequency of Allergic Bronchopulmonary Aspergillosis in Bronchiectasis-COPD Overlap.
PubMed 文献 · Chest · 2021-08-05

这项前瞻性横断面研究在三国六家医院纳入280例稳定期患者,包括支气管扩张183例、慢阻肺50例和支气管扩张-慢阻肺重叠(BCO)47例,评估烟曲霉致敏与变应性支气管肺曲霉病(ABPA)的发生及临床相关性。结果显示BCO患者ABPA的发生频率和临床严重程度高于单纯慢阻肺或支气管扩张患者,且BCO合并ABPA与更严重疾病、更高急性加重率和更低肺功能相关。BCO合并严重支气管扩张严重指数(BSI>9)与ABPA发生显著相关,且不依赖于慢阻肺严重程度。

要点

  • BCO患者ABPA发生频率和临床严重程度高于单纯慢阻肺或支气管扩张患者。
  • BCO合并ABPA者疾病更重、急性加重率更高、肺功能更低。
  • BCO合并BSI>9与ABPA发生显著相关,临床应高度警惕。

核心结论

  • BCO患者中ABPA发生频率高,与严重BSI(>9)及不良临床结局相关。
  • 临床医生应对高BSI的BCO患者保持对ABPA的高度警惕。

研究设计与样本

  • 前瞻性、观察性、横断面研究,在临床稳定期招募患者。
  • 共纳入280例患者,来自新加坡、马来西亚和苏格兰六家医院。
  • 患者包括支气管扩张183例、慢阻肺50例和BCO 47例。
  • 评估对一组重组烟曲霉过敏原的特异性IgE致敏反应及ABPA发生与临床结局的关系。

主要发现

  • BCO患者ABPA的发生频率和临床严重程度高于单纯慢阻肺和单纯支气管扩张患者。
  • BCO相关ABPA与更严重疾病、更高急性加重率和更低肺功能相关,相比无重叠的ABPA。
  • BCO合并严重BSI(>9)与ABPA发生显著相关,且不依赖于基础慢阻肺严重程度。

关键数值与推荐

  • BCO患者中严重支气管扩张严重指数(BSI)>9与ABPA发生显著相关。

临床怎么用

  • 对BCO患者应警惕ABPA可能,尤其当BSI>9时。
  • BCO合并ABPA提示疾病更重、急性加重更多、肺功能更差,需加强评估与管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Allergic bronchopulmonary aspergillosis (ABPA) is associated with frequent exacerbations and poor outcomes in chronic respiratory disease, but remains underdiagnosed. The role of fungal sensitization in bronchiectasis-COPD overlap (BCO) is unknown. RESEARCH QUESTION: What is the occurrence and clinical relevance of Aspergillus sensitization and ABPA in BCO when compared with individuals with COPD or bronchiectasis without overlap? STUDY DESIGN: Prospective, observational, cross-sectional study. METHODS: We prospectively recruited 280 patients during periods of clinical stability with bronchiectasis (n = 183), COPD (n = 50), and BCO (n = 47) from six hospitals across three countries (Singapore, Malaysia, and Scotland). We assessed sensitization responses (as specific IgE) to a panel of recombinant Aspergillus fumigatus allergens and the occurrence of ABPA in relationship to clinical outcomes. RESULTS: Individuals with BCO show an increased frequency and clinical severity of ABPA compared with those with COPD and bronchiectasis without overlap. BCO-associated ABPA is associated with more severe disease, higher exacerbation rates, and lower lung function when compared with ABPA occurring in the absence of overlap. BCO with a severe bronchiectasis severity index (BSI; > 9) is associated significantly with the occurrence of ABPA that is unrelated to underlying COPD severity. CONCLUSIONS: BCO demonstrates a high frequency of ABPA that is associated with a severe BSI (> 9) and poor clinical outcomes. Clinicians should maintain a high index of suspicion for the potential development of ABPA in patients with BCO with high BSI.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Tiew PY, Lim AYH, Keir HR, et al. High Frequency of Allergic Bronchopulmonary Aspergillosis in Bronchiectasis-COPD Overlap. Chest. 2021. PMID: 34364870. doi:10.1016/j.chest.2021.07.2165

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。